The meeting is routine, but the recent appointment of Habib Dable and the election of two other new directors (Moran and More) suggest potential shifts in board composition. Monitor for any unexpected outcomes in the vote, though the board's recommendation is for approval.
TYRA drugs
TYRA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 17 $35.56entry
- T+1 · 7mo ago −3.35%α −3.15% · $34.37
- T+5 · 7mo ago +5.71%α +5.15% · $37.59
- T+20 · 6mo ago +2.67%α −2.70% · $36.51
- T+60 · 4mo ago −7.54%α −13.68% · $32.88
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Tyra Biosciences is holding its annual shareholder meeting to elect three directors, including Habib J. Dable, whose recent appointment was previously disclosed. The board recommends voting for all proposals, including the ratification of Ernst & Young as auditors. This filing follows recent board changes, suggesting ongoing governance activity.
Key Financial Metrics
Key Facts
- The annual meeting will be held on May 28, 2026.
- Three directors are up for election: Habib J. Dable, Susan Moran, and Robert More.
- Ernst & Young LLP is up for ratification as the independent auditor.
- The board recommends a vote FOR all proposals.
- Habib J. Dable was recently appointed to the board on April 16, 2026, as disclosed in an 8-K filing.
Financial Impact
None disclosed.
Risk Factors
- Potential for shareholder dissent on director elections, though the board recommends approval.
- Recent board changes could indicate internal strategy shifts or governance issues.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-160364 |
| Document: 0001193125-26-160364-index-headers.html | 0001193125-26-160364 |
| Document: 0001193125-26-160364-index.html | 0001193125-26-160364 |
| Document: 0001193125-26-160364.txt | 0001193125-26-160364 |
Track record
13 reports on TYRA
3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +20.37% at T+60 after the Jun 26, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $21.00 Now $19.74 −6.00% settles Nov 17
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $21.75 to $21.53 Now $19.74 −9.24% ▼ −1.03% −0.32% vs SPY
- Sep 21, 20268w ago SC 13G Neutral 4/10 Entry $25.57 to $21.98 Now $19.74 −22.80% ▼ −14.04% −12.85% vs SPY
- Sep 17, 20268w ago Insider Cluster Bullish 8/10 Entry $25.73 to $21.76 Now $19.74 −23.28% ▼ −15.43% −16.70% vs SPY
- Sep 14, 20269w ago S-3ASR Neutral 3/10 Entry $25.07 to $25.65 Now $19.74 −21.26% ▲ +2.31% +2.21% vs SPY
- Sep 9, 20269w ago 8-K Bullish 6/10 Entry $22.01 to $24.35 Now $19.74 −10.31% ▲ +10.63% +11.73% vs SPY
- Aug 4, 202614w ago 424B5 Bearish 6/10 Entry $25.71 to $25.30 Now $19.74 +23.22% ▲ +1.59% +1.95% vs SPY
- Jun 26, 202620w ago 144 Bearish 6/10 Entry $32.11 to $30.86 Now $19.74 +38.52% ▲ +3.89% +5.28% vs SPY
- May 13, 202626w ago 8-K Mixed 5/10 Entry $36.19 to $33.78 Now $19.74 −45.45% ▼ −6.66% −5.50% vs SPY
- Apr 20, 202630w ago 3 Neutral 2/10 Entry $36.69 to $35.06 Now $19.74 −46.20% ▼ −4.44% −5.53% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers